A DNA sequencing-based neuromuscular genetic panel identified a heterozygous pathogenic variant and two variants of uncertain significance in his PGAM2 genes, leading to a diagnosis of glycogen storage disease X. Here, PGAM2 is linked to glycogen storage disease due to phosphoglycerate mutase deficiency.